Magdalena Jonikas

Magdalena is a non-executive Director of OMass Therapeutics. She is a partner of Syncona Investment Management Ltd and previously was an Associate Partner at McKinsey & Company where she specialised in pharmaceuticals Research & Development, portfolio management and Business Development and Licensing. Magdalena holds a PhD in Bioengineering from Stanford University and was a postdoctoral fellow in Harvard Medical School’s Computational Health Informatics Programme.